Education
About Us
Working with TipRanks
Follow Us
Pasithea Therapeutics Corp (KTTA)
NASDAQ:KTTA
Total Valuation
Pasithea Therapeutics Corp has a market cap or net worth of $26.43M. The enterprise value is ―.
Market Cap$26.43M
Enterprise Value―
Share Statistics
Pasithea Therapeutics Corp has 22,398,920 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding22,398,920
Owned by Insiders1.66%
Owned by Institutions1.37%
Financial Efficiency
Pasithea Therapeutics Corp’s return on equity (ROE) is -0.94 and return on invested capital (ROIC) is -95.35%.
Return on Equity (ROE)-0.94
Return on Assets (ROA)-0.87
Return on Invested Capital (ROIC)-95.35%
Return on Capital Employed (ROCE)-0.95
Revenue Per Employee0.00
Profits Per Employee-3.48M
Employee Count4
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Pasithea Therapeutics Corp is ―. Pasithea Therapeutics Corp’s PEG ratio is -0.79.
PE Ratio―
PS Ratio0.00
PB Ratio0.23
Price to Fair Value0.23
Price to FCF>-0.01
Price to Operating Cash Flow>-0.01
PEG Ratio-0.79
Income Statement
In the last 12 months, Pasithea Therapeutics Corp had revenue of 0.00 and earned -13.90M in profits. Earnings per share was -12.69.
Revenue0.00
Gross Profit0.00
Operating Income-14.25M
Pretax Income-13.90M
Net Income-13.90M
EBITDA-13.60M
Earnings Per Share (EPS)-12.69
Cash Flow
In the last 12 months, operating cash flow was -12.26M and capital expenditures -6.00, giving a free cash flow of -12.26M billion.
Operating Cash Flow-12.26M
Free Cash Flow-12.26M
Free Cash Flow per Share-0.55
Dividends & Yields
Pasithea Therapeutics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta4.22
52-Week Price Change-58.42%
50-Day Moving Average0.87
200-Day Moving Average0.91
Relative Strength Index (RSI)59.09
Average Volume (3m)98.68K
Important Dates
Pasithea Therapeutics Corp upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Pasithea Therapeutics Corp as a current ratio of 6.58, with Debt / Equity ratio of 0.00%
Current Ratio6.58
Quick Ratio6.58
Debt to Market Cap0.00
Net Debt to EBITDA0.52
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Pasithea Therapeutics Corp has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Pasithea Therapeutics Corp EV to EBITDA ratio is 0.26, with an EV/FCF ratio of <0.01.
EV to Sales0.00
EV to EBITDA0.26
EV to Free Cash Flow<0.01
EV to Operating Cash Flow<0.01
Balance Sheet
Pasithea Therapeutics Corp has $4.12M in cash and marketable securities with $0.00 in debt, giving a net cash position of $4.12M billion.
Cash & Marketable Securities$4.12M
Total Debt$0.00
Net Cash$4.12M
Net Cash Per Share$0.18
Tangible Book Value Per Share$5.66
Margins
Gross margin is 0.16%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.16%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Pasithea Therapeutics Corp is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.00
Price Target Upside158.62% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast―